Senti Biosciences SNTI
-
-
-
已收盤：-
本益比明細
年季 | 收盤價 | 本業佔比% | 本益比(近四季) | 每股稅後盈餘(元) | 營業利益(千) | 稅後純益(百萬) |
|---|---|---|---|---|---|---|
| 2025Q1 | 3.36 | 116.19 | -1.41 | -16,397 | -14 | |
| 2024Q4 | 3.51 | 2650.33 | -0.62 | -16,167 | -1 | |
| 2024Q3 | 2.26 | 52.71 | -6.31 | -15,215 | -29 | |
| 2024Q2 | 2.76 | 119.22 | -2.45 | -13,356 | -11 | |
| 2024Q1 | 3.77 | 134.60 | -2.65 | -16,301 | -12 | |
| 2023Q4 | 6.60 | 100.05 | -4.19 | -18,698 | -19 | |
| 2023Q3 | 4.13 | 119.83 | -3.35 | -43,876 | -15 | |
| 2023Q2 | 6.27 | 103.98 | -4.27 | -24,505 | -19 | |
| 2023Q1 | 11.80 | 105.94 | -4.20 | -19,834 | -19 | |
| 2022Q4 | 14.10 | 107.67 | -2.40 | -25,339 | -18 | |
| 2022Q3 | 21.70 | 102.67 | 8.10 | -17,085 | -17 | |
| 2022Q2 | 19.65 | 188.45 | 9.20 | -21,770 | -12 | |
| 2022Q1 | 98.70 | 101.76 | -37.20 | -1,333 | -1 | |
| 2021Q4 | 98.60 | -36.70 | -10,885 | -11 | ||
| 2021Q3 | 99.40 | 100.15 | -38.80 | -11,423 | -11 | |
| 2021Q2 | 99.40 | -2.75 | -8,996 | -12 |